KRP-103

NK1 receptor antagonist; structure in first source

Also Known As:

2-(4-acetylpiperadin-1-yl)-6-(3,5-bis(trifluoromethyl)phenylmethyl)-4-(2-methylphenyl)-6,7,8,9-tetrahydro-5H-pyrimido(4,5-b)(1,5)oxazocin-5-one

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)